Abstract
Although drug prescribing is one of the most important components of medical care, little is known about how prescribing practices are determined and how they can be influenced. Enhancing the quality and effectiveness of drug prescribing requires research and better dissemination of information to physicians and other decision-makers. This requires a collaborative effort and a coordinated action plan. Participants at the Physician Prescribing Practices Workshop, held in Ottawa in October 1995, addressed issues and made recommendations in three areas: current knowledge and issues for research in the field of prescribing practices, and the capacity of Canadian databases to study these issues, strategies for disseminating and implementing knowledge and research findings to enhance the quality of prescribing; and the formation of a network to foster collaboration among stakeholders.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- Anderson G. M., Lexchin J. Strategies for improving prescribing practice. CMAJ. 1996 Apr 1;154(7):1013–1017. [PMC free article] [PubMed] [Google Scholar]
- Anis A. H., Carruthers S. G., Carter A. O., Kierulf J. Variability in prescription drug utilization: issues for research. CMAJ. 1996 Mar 1;154(5):635–640. [PMC free article] [PubMed] [Google Scholar]
- Holbrook A. M., MacLeod S. M., Fisher P., Levine M. A. Developing a Canadian prescribing practices network. Network Development Committee of the Canadian Prescribing Practices Network Project. CMAJ. 1996 May 1;154(9):1325–1331. [PMC free article] [PubMed] [Google Scholar]
- Turka L. A., Ledbetter J. A., Lee K., June C. H., Thompson C. B. CD28 is an inducible T cell surface antigen that transduces a proliferative signal in CD3+ mature thymocytes. J Immunol. 1990 Mar 1;144(5):1646–1653. [PubMed] [Google Scholar]